Medtronic's 4th-quarter profits plunged nearly 54% on its $750 million settlement with Edwards Lifesciences over replacement heart valve technology.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1lJIqcp
Cap comentari:
Publica un comentari a l'entrada